Clinical Trials on Liver Cell Damage in New Zealand
Total 8063 results
-
University of Auckland, New ZealandAuckland District Health BoardUnknownPeritoneal Dessication Damage and Inflammation | Peri-operative HypothermiaNew Zealand
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Auckland District Health BoardNovartis; University of Auckland, New Zealand; IGENZ, Ltd., AucklandUnknownClear Cell Renal Cell CarcinomaNew Zealand
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Alios Biopharma Inc.Completed
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Columbia UniversityCompleted
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
University of Auckland, New ZealandUniversity of Otago; AgResearchCompletedWell-beingNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedMucositis | Xerostomia | Radiation Toxicity | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Nasopharynx | Stage III Squamous Cell Carcinoma... and other conditionsUnited States, New Zealand
-
Novartis PharmaceuticalsTerminated
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Gilead SciencesCompleted
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Arrowhead PharmaceuticalsCompleted
-
Antipodean Pharmaceuticals, Inc.Completed
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Arrowhead PharmaceuticalsTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Assembly BiosciencesCompleted
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Gilead SciencesCompleted
-
Alios Biopharma Inc.TerminatedHepatitis B | Chronic Hepatitis B | Viral Hepatitis BNew Zealand
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)United States, New Zealand
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
AbbVieCompletedHepatic ImpairmentUnited States, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
University of New MexicoWithdrawn
-
University of ZurichUniversity Hospital, Strasbourg, France; University College London Hospitals; University Hospital, Essen and other collaboratorsCompletedNeoplasmsUnited Kingdom, Germany, Switzerland, United States, France, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Rutgers, The State University of New JerseyNatera, Inc.; BioGene Pharmaceutical Ltd.RecruitingCarcinoma, Hepatocellular | Liver Cell CarcinomaUnited States
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France